Adult
Conditions
Interventions
Apply the three test products (lotion, serum, and cream) twice daily after washing in the morning and evening. Continue this for up to 12 weeks.
Sponsors
ROHTO Pharmaceutical Co., Ltd.
Shin-Kawasaki Eve Clinic for Dermatology and Aesthetic Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Individuals aged 18 or older at the time of consent acquisition 2) Individuals who have received sufficient explanation regarding the purpose and content of this trial, possess the capacity to consent, voluntarily volunteer to participate after fully understanding, and can provide written consent to participate in this study.
Exclusion criteria
Exclusion criteria: Individuals 1) who used the products containing stem cell culture supernatant within 4 weeks. 2) at risk of developing allergies related to ingredients in this trial cosmetic or to cosmetics. 3) who are pregnant, breastfeeding, may be pregnant, or plan to become pregnant during the study. 4) in other clinical trial within 4 weeks. 5) considered unsuitable for the study by the principle investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin conditions 1)VISIA's indicators 2)Trans epidermal water loss 3)Stratum corneum moisture content 4)Mexameter's score | — |
Secondary
| Measure | Time frame |
|---|---|
| Subject self-assessment | — |
Countries
Japan
Contacts
Public ContactMiwako Shidomi
ROHTO Pharmaceutical Co., Ltd. Health Science & Data Planning Division
Outcome results
None listed